Neurostimulation to Treat Parkinson’s Disease
If you have been following our insights over the past few weeks, you have likely seen quite a few insights involving neurostimulation treatments. This relatively new treatment method has been utilized for everything from dieting to epilepsy control. This past week, the National University of Ireland had a patent publish (U.S. Pat. No. 10744324) that teaches using neurostimulation to treat Parkinson’s disease.
Parkinson’s disease is a brain disorder that leads to shaking, stiffness, and difficulty with walking, balance, and coordination. Although there is presently no cure for Parkinson’s, technologies have been developed to help treat symptoms. One such of those treatments is disclosed in the ‘4324 patent, which teaches using a combination of sensors and neurostimulation electrodes on the legs to help those who have difficulty walking due to Parkinson’s. Make sure to subscribe to the Magic Number® AI Biotech/Diagnostic Patent Forecast® to stay up to date with the most recent patent activity involving emerging treatments and new players to the sector!

Related Posts
April 15, 2021
Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…
AI Biotech / Diagnostics,AI Biotech / Diagnostics: Activity,AI Biotech / Diagnostics: Neurology
April 8, 2021
Capital One is Investing in AI Biotech? What’s in their wallet?
In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…
April 1, 2021
Google AI Reinvents Speech Recognition. Who will follow?
There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…
AI Biotech / Diagnostics,AI Biotech / Diagnostics: Neurology


